Objective: To compare clinical outcomes of premature infants on synchronized nasal intermittent positive pressure ventilation (SNIPPV) vs nasal intermittent positive pressure ventilation (NIPPV) in the neonatal intensive care unit. Use of NIPPV in the neonatal intensive care unit has shown promise with better clinical outcomes in premature neonates. It is not known if synchronization makes a significant clinical impact when using this technique.
Introduction
Nasal intermittent positive pressure ventilation (NIPPV) is a form of non-invasive ventilatory assistance using a nasal interface to provide respiratory support. 1 NIPPV has been shown to be superior to nasal continuous positive airway pressure (NCPAP) or conventional mechanical ventilation, as a method of reducing the incidence of extubation failure and pulmonary morbidities including bronchopulmonary dysplasia (BPD). 1 NIPPV may be synchronized (SNIPPV) or non-synchronized to the infants breathing efforts. Many randomized controlled trials (RCT) have been conducted proving the efficacy of SNIPPV/NIPPV in keeping the infant extubated and/or decreasing BPD compared with other modes of respiratory support. [2] [3] [4] [5] [6] [7] [8] The effectiveness of SNIPPV could be due to the decrease in the thoraco-abdominal motion asynchrony and flow resistance through nasal prongs, with improved stability of chest wall and pulmonary mechanics. 9 Addition of peak inspiratory pressure above the positive end expiratory pressure by using SNIPPV leads to increased intermittent distending pressure above the positive end expiratory pressure, with increased flow delivery in the upper airway. 2 Moretti et al. 10 reported that application of SNIPPV was associated with increased tidal and minute volumes when compared with NCPAP in the same infant. It is also possible that SNIPPV recruits collapsed alveoli and increases functional residual capacity. Aghai et al. 11 have reported that infants receiving SNIPPV have decreased work of breathing.
There is limited information available comparing the effectiveness of SNIPPV vs NIPPV. The goal of the present study was to compare the clinical outcomes of infants who were managed with SNIPPV versus those infants who were on NIPPV anytime during their stay in the newborn special care unit at Yale.
Methods
At Yale, before 2007, NIPPV was delivered through a ventilator, which synchronized breaths with infant's respiratory efforts and was termed SNIPPV. SNIPPV was delivered using the Infant Star ventilator with StarSync (Infrasonics Inc., San Diego, CA, USA), and synchronization with infant's respiratory efforts was achieved utilizing the Graseby capsule. NIPPV replaced SNIPPV, as the Infant Star ventilator was phased out of production in the United States. From 2007, NIPPV has been utilized using the Bear Cub 750 psv (CareFusion, San Diego, CA, USA) ventilator.
Clinical retrospective data were collected on infants (n ¼ 410) admitted to the newborn special care unit at Yale-New Haven Children's Hospital (New Haven, CT, USA) from 1 January 2004 to 31 December 2009. The criteria for inclusion were all infants who were admitted to newborn special care unit and received SNIPPV/ NIPPV anytime during their stay. BPD was defined using the National Institutes of Health (NIH) consensus definition. 12 Data collection was approved by the Yale institutional review board (Human Investigation Committee).
Clinical data collection
The maternal and neonatal characteristics have been shown in Supplementary Table 1 . Antenatal steroid treatment was defined as at least a 12 h interval between maternal dosing and subsequent delivery of the infant. Resuscitation after birth was defined as being given bag and mask ventilation and/or intubation and/or chest compression and/or drugs. Patent ductus arteriosus was documented by echocardiography. Intraventricular hemorrhage was determined according to Papile's classification of blood in the germinal matrix or ventricular system with or without ventricular dilatation and parenchymal extension. 13 Periventricualr leukomalacia was defined as cerebral ultrasound findings of increased echogenicity and cystic lesions in the periventricular white matter. 14 Sepsis was diagnosed by a positive blood culture. Necrotizing enterocoloitis was defined as Xstage 2 as per the modified Bell's criteria. 15 Retinopathy of prematurity was defined as per the international classification. 16 Infants were classified into two different groups, based on the type of respiratory support they received, SNIPPV (2004 SNIPPV ( to 2006 and NIPPV (2007 to 2009). The main outcome of the study was incidence of BPD/death in the groups.
Statistical analyses
Maternal, perinatal and neonatal characteristics of infants in the two groups of respiratory support (SNIPPV and NIPPV), as well as unadjusted associations between potential risk factors and BPD/death were compared using w 2 -or Wilcoxon rank-sum test. Adjusted analyses for the probability of having BPD/death were performed using generalized linear mixed models, taking into account correlation among infants of multiple gestation. A P-value of p0.05 was considered statistically significant. Data were analyzed using SAS 9.2 (SAS Institute, Cary, NC, USA).
Results
Out of the total 410 infants included in the study, 172 were classified into SNIPPV group and 238 into NIPPV group. As already mentioned, the classification was based on the type of NIPPV, synchronized (2004 to 2006) or non-synchronized (2007 to 2009).
Supplementary Table 1 lists the demographic and clinical characteristics of infants in both groups. There was no significant difference in the mean gestational age and birth weight between the two groups. There was also no difference in gender, maternal age, antenatal steroids, small for gestational age and Apgar scores in the two groups.
More infants in the NIPPV group were given resuscitation (63 vs 44.2%, P<0.001) whereas more infants in SNIPPV group needed surfactant administration (84.4 vs 70.2%, P<0.001).
There was no significant difference in the duration of endotracheal tube (ETT) ventilation or SNIPPV/NIPPV in infants in the two groups, but infants in NIPPV were exposed to NCPAP for slightly longer duration of time (P<0.02) ( Table 1) .
No differences were noted in the rate of sepsis, patent ductus arteriosus, intraventricular hemorrhage, periventricular leukomalacia, retinopathy of prematurity and necrotizing enterocolitis in the two groups (Table 1 ).
There were eight deaths in the SNIPPV group and nine in the NIPPV group. There were no instances of intestinal perforation in the SNIPPV group; however, there were 12 instances of intestinal perforation in the NIPPV group out of which 10 were spontaneous intestinal perforations. Details have been provided in Table 2 .
Based on unadjusted analyses, BPD/death was significantly increased in the SNIPPV group (63.4 vs 51.6%, P<0.02). After adjusting for variables such as birth weight, gender, race, given resuscitation, sepsis, surfactant administration, and days on total parenteral nutrition ( Table 3) , use of NIPPV, as compared with SNIPPV, was not associated with increased probability of BPD/death (odds ratio 0.74; 95% confidence interval 0.42, 1.30).
Discussion
With the increased interest in nasal ventilation as the primary mode of respiratory support in premature infants to reduce extubation failure and/or BPD, it is important to know if synchronization has any added benefit. Studies have been conducted and are ongoing, comparing SNIPPV/NIPPV with other modes of ventilation, but no study has reported on detailed clinical outcomes, comparing SNIPPV with NIPPV.
Moretti et al. conducted a study in which infants weighing <1251 g with respiratory distress syndrome requiring mechanical ventilation at 48 h of age were extubated randomly to SNIPPV or NCPAP, once the criteria were met. Infants in SNIPPV group had a higher incidence of successful extubation compared with those in NCPAP group (90 vs 61%, P ¼ 0.005). 6 In our previous studies, it Synchronization of NIPPV V Dumpa et al has been shown that SNIPPV decreased the duration of intubation and the need for supplemental oxygen as compared with mechanical ventilation in premature infants with respiratory distress syndrome. 17 In a subsequent RCT, comparing SNIPPV with ETT ventilation, it was shown that infants in SNIPPV group had fewer outcomes of BPD/death compared with those in ETT group (20 vs 52%, P ¼ 0.03). 4 The long-term outcomes of premature infants managed on SNIPPV were comparable to those of infants managed on conventional ventilation. In a RCT done using SNIPPV, no differences were reported in the mental or psychomotor developmental index scores on follow up between the infants managed with SNIPPV or continued on conventional mechanical ventilation. 4 In another large retrospective study done to evaluate use of SNIPPV in infants p1250 g, it was observed that, infants who received SNIPPV (compared with those who received NCPAP) in the birth weight category 500 to 750 g were significantly less likely to have the long-term outcomes of BPD, BPD/death, neurodevelopmental impairment and neurodevelopmental impairment/death. It is again worth mentioning that no study has been done reporting on long-term outcomes on infants managed with SNIPPV vs NIPPV. 18 Studies done comparing NIPPV to other modes of ventilation have also yielded similar outcomes. Kugelman et al. 7 showed that infants treated initially with NIPPV needed less ETT ventilation (25 vs 49%, P<0.05), had decreased incidence of BPD (2 vs 17%, P<0.05), compared with infants treated initially with NCPAP. Similarly, in another RCT comparing infants with respiratory distress syndrome receiving NIPPV within 6 hours, to those receiving NCPAP, it was shown that infants on NIPPV had lower rates of extubation failure, but had similar rates of BPD. 8 Khorana et al. 19 conducted a RCT comparing NIPPV and NCPAP, in which premature infants were randomized to either of the two groups after extubation. The primary outcome of reintubation rates and other measured outcomes such as apnea, abdominal distension, sepsis and necrotizing enterocolitis were not significantly different in both groups. However, the two groups of NIPPV and NCPAP were not well matched: infants in NIPPV group had lower mean birth weight, higher rates of respiratory distress syndrome and antenatal steroid use. 19 Also, after extubation, in the NIPPV group, the peak inspiratory pressure was not increased by 4 cm H 2 O above that required during manual ventilation, 19 as has been recommended. 1 Kumar et al. 20 conducted a RCT recently, comparing NIPPV to 'oxygen by head box' and found that NIPPV significantly reduced extubation failure. The timing of initiation of SNIPPV/NIPPV is also a key factor in the outcome of BPD/death. In a recent study conducted by our group, it was observed that infants who were on NIPPV for most of the time in the first week of life compared with being on ETT, had a decreased incidence of BPD/death. 21 There have been two reports, comparing SNIPPV with NIPPV, evaluating short-term effects. Recently, Chang et al. 22 studied the effects of synchronization during nasal ventilation comparing nasal intermittent mandatory ventilation, synchronized nasal intermittent mandatory ventilation and NCPAP in a randomized manner, each for 1 h. They concluded that synchronized nasal ventilation reduced breathing effort and resulted in better infantventilator interaction than non-synchronized nasal ventilation. Owen et al. 23 studied effects of NIPPV on spontaneous breathing and proposed that synchronization of NIPPV pressure peaks with spontaneous inspirations may increase the benefits of NIPPV.
Our present study compares SNIPPV vs NIPPV by examining the clinical characteristics of infants and the clinical outcome of BPD/death. Neither mode of nasal ventilation was found to be superior with respect to these outcomes. The most serious complication associated with the use of SNIPPV/NIPPV in neonates has been gastrointestinal perforation. 24 Use of SNIPPV has been associated with a 'reassuring absence of gastrointestinal side effects'. 25 In the present study, the rate of intestinal perforations was higher during the NIPPV study period. However, these perforations occurred with the infants being on different modes of ventilation. Hence, we were unable to specifically associate gastrointestinal perforations with SNIPPV or NIPPV use, as had been reported in the pre-surfactant era publication. 24 The study by Sai Sunil Kishore et al. 8 noted a slight increase in abdominal distension in the NIPPV group vs conventional mechanical ventilation, but this difference was not statistically significant. Furthermore, there was no difference in the tolerance of feeds. 8 In our study, days on total parenteral nutrition were lower in a trend favoring NIPPV. Thus, it would appear that the suggested guidelines on the technique of providing (S)NIPPV are safe. 1 The major limitation to our study is its retrospective nature. However, the strengths of the study include the large sample size, detailed evaluation of clinical outcomes based on mode of respiratory support and the use of NIH consensus definition for BPD.
Conclusion
Use of SNIPPV relative to NIPPV did not show a significantly different impact on clinical outcomes in premature infants.
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